Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562

Holyoake, T L and Allan, E K and Mountford, J C and Richmond, L and Harrison, S J and Elliott, M A and Jorgensen, H G (2003) Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562. Blood, 102 (11). 654A-654A. 2420. ISSN 0006-4971

Full text not available in this repository.Request a copy from the Strathclyde author

Abstract

Meeting abstract 2420 looks at pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line, K562.